Претрага

Резултати

The second revision of international staging system (R2-ISS) in newly diagnosed multiple myeloma patients: RWE settings [2023]

Sretenović, Aleksandra M.; Mitrović, Marko; Vukosavljević, Nikola; Kecman, Natalija; Jovanović, Jelica V.; Bukumirić, Zoran M. ; Bila, Jelena S.

Generic Imatinib in Chronic Myeloid Leukemia Treatment: Long-Term Follow-up [2019]

Ćojbašić, Irena ; Mačukanović-Golubović, Lana ; Vučić, Miodrag ; Ćojbašić, Žarko

Analyses of Treatment Outcome According to Age in Patients With Chronic Myeloid Leukemia Receiving Front-line Imatinib Therapy [2017]

Ćojbašić, Irena ; Mačukanović Golubović, Lana ; Vučić, Miodrag ; Tijanić, Ivan

Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma [2016]

Bila, Jelena ; Sretenovic, Aleksandra; Jelicic, Jelena ; Tošić, Nataša ; Glumac, Irena ; Fekete, Marija Dencic; Antić, Darko ; Todorović, Milena ; Marković, Olivera ; Milojevic, Zoran;

Radojković, Milica ; Trajković, Goran ; Puric, Mila; Pavlović, Sonja ; Mihaljević, Biljana ;

Early Evaluation and Therapy Adjustment in Advanced Stage Hodgkin Lymphoma-The Role of PET/CT [2019]

Tucović, Aleksandra; Purić, Mila; Milanović, Nenad ; Đorđević, Feđa; Artiko, Vera ; Šobić-Šaranović, Dragana

Assessment of Symptom Burden Among Patients Diagnosed with Multiple Myeloma (MM) Admitted to Receive Chemotherapy at the Institute for Oncology and Radiology of Serbia (IORS) [2018]

Djordjevic, Fedja R

Prognostic Effect of Comorbidity Indices in Elderly Patients With Multiple Myeloma [2015]

Bila, Jelena ; Jeličić, Jelena ; Đurašinović, Vladislava; Vuković, Vojin ; Sretenović, Aleksandra; Anđelić, Boško; Antić, Darko ; Todorović, Milena ; Mihaljević, Biljana

Ultra-high-risk prognostic significance of double and triple hit myeloma [2021]

Bila, Jelena S. ; Mitrović, Marko; Bukumirić, Zoran M. ; Jovanović, Jelica V.; Denčić-Fekete, Marija ; Sretenović, Aleksandra M.; Jeličić, Jelena J. ; Perić, Teodora; Mihaljević, Biljana S. ; Antić, Darko A.

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group [2025]

Fotiou, Despina; ...; Bila, Jelena S. ; ...; Sretenović, Aleksandra; Marković, Olivera ; ...; Cvetković, Zorica P. ; ...; (broj koautora 23)

Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy [2023]

Mateos, Maria-Victoria; Szarejko, Monika; Bila, Jelena S. ; Schjesvold, Fredrik; Spicka, Ivan; Maisnar, Vladimir; Jurczyszyn, Artur; Grudeva-Popova, Zhanet; Hajek, Roman; Usenko, Hanna;

Thuresson, Marcus; Norin, Stefan; Jarefors, Sara; Richardson, Paul; Pour, Ludek;